Health
AstraZeneca launches cost-cutting program
AstraZeneca has initiated a three-year cost-cutting plan aimed at reducing annual expenses by $1.5 billion, with the savings to be reinvested in research and development.
Coverage timeline — 1 article
STAT News
AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D
2026-10-30 13:22 UTC